CIK 0001541157
- Non-accelerated filer
- Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- EIN
- 981034922
- Phone
- +1 929-274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- F-6EF Other F-6EF
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- NT 20-F Other Notification of Inability to Timely File
- EFFECT Other Notice of Effectiveness
- F-3/A Offering F-3/A
- F-3 Offering F-3
- DEFA14A Proxy Proxy Materials
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- D Other Notice of Sales of Unregistered Securities
Page 5 of 8 · 145 filings